Thoracoscopy Versus Fibrinolysis in Children With Empyema

Completed · Phase 2/Phase 3

Conditions studied: Empyema

In brief

The null hypothesis is that patients receiving either thoracoscopy or fibrinolysis for empyema recover in the same amount of time. Therefore, we will test this by randomizing the next 40 patients who consent to the study to one treatment or the other.

Key facts

Study ID

NCT00323531

Run by

Children's Mercy Hospital Kansas City

People needed

36

Starts

2006-03-01

Expected to finish

2007-10-01

Last updated by the study team

2008-05-09

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients less than 18 years of age requiring an intervention for empyema by one of the following:
• Septation or loculation seen on ultrasound or computed tomography
• Many white blood cells, bacteria present, or thick viscid purulence identified on pleural tap

You may not qualify if…

• Immunodeficiency process
• Secondary diagnosis or condition that will keep them in the hospital beyond the empyema
• Existing contraindications to VATS or chest tube.

Where it is running

• Children's Mercy Hospital — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.